R T Chlebowski - JoVE Visualize

Showing results (41-50 of 76) with videos related to

Pageof 8

Sort By:

The American Journal of the Medical Sciences|August 1, 1995

Altered metabolism and mortality in patients with colon cancer receiving chemotherapyJ A Tayek, L Sutter, S Manglik, et al.

The American Journal of Gastroenterology|October 1, 1989

Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDSR T Chlebowski, M B Grosvenor, N H Bernhard, et al.

Cancer|January 15, 1985

Influence of nutritional status on circulatory ribonuclease C levels in patients with cancerR T Chlebowski, S B Abramson, J R Bateman, et al.

Breast Cancer Research and Treatment|September 1, 1993

The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patientsD P Rose, J M Connolly, R T Chlebowski, et al.

The Journal of Pharmacology and Experimental Therapeutics|February 1, 1987

Synergistic cytotoxicity between menadione and dicumarol vs. murine leukemia L1210S A Akman, J H Doroshow, M F Dietrich, et al.

Cancer Treatment Reports|March 1, 1984

Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic resultsR T Chlebowski, A Brzechwa-Adjukiewicz, A Cowden, et al.

Cancer|October 15, 1986

Pathophysiology of malnutrition in the adult cancer patientD Heber, L O Byerley, J Chi, et al.

International Journal of Nuclear Medicine and Biology|January 1, 1982

Dosimetry and preliminary human studies of 18F-5-fluorouracilJ Shani, D Young, T Schlesinger, et al.

American Journal of Clinical Oncology|April 1, 1985

Doxorubicin, cyclophosphamide, CCNU, and vincristine with or without cisplatinum in non-small cell lung cancerR T Chlebowski, J S Chlebowski, J Herrold, et al.

Climacteric : the Journal of the International Menopause Society|May 14, 2015

Reliable evidence from placebo-controlled, randomized, clinical trials for menopausal hormone therapy's influence on incidence and deaths from breast cancerR T Chlebowski, G L Anderson, R L Prentice, et al.

Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:

Pageof 8

The American Journal of the Medical Sciences|August 1, 1995

Altered metabolism and mortality in patients with colon cancer receiving chemotherapyJ A Tayek, L Sutter, S Manglik, et al.

The American Journal of Gastroenterology|October 1, 1989

Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDSR T Chlebowski, M B Grosvenor, N H Bernhard, et al.

Cancer|January 15, 1985

Influence of nutritional status on circulatory ribonuclease C levels in patients with cancerR T Chlebowski, S B Abramson, J R Bateman, et al.

Breast Cancer Research and Treatment|September 1, 1993

The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patientsD P Rose, J M Connolly, R T Chlebowski, et al.

The Journal of Pharmacology and Experimental Therapeutics|February 1, 1987

Synergistic cytotoxicity between menadione and dicumarol vs. murine leukemia L1210S A Akman, J H Doroshow, M F Dietrich, et al.

Cancer Treatment Reports|March 1, 1984

Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic resultsR T Chlebowski, A Brzechwa-Adjukiewicz, A Cowden, et al.

Cancer|October 15, 1986

Pathophysiology of malnutrition in the adult cancer patientD Heber, L O Byerley, J Chi, et al.

International Journal of Nuclear Medicine and Biology|January 1, 1982

Dosimetry and preliminary human studies of 18F-5-fluorouracilJ Shani, D Young, T Schlesinger, et al.

American Journal of Clinical Oncology|April 1, 1985

Doxorubicin, cyclophosphamide, CCNU, and vincristine with or without cisplatinum in non-small cell lung cancerR T Chlebowski, J S Chlebowski, J Herrold, et al.

Climacteric : the Journal of the International Menopause Society|May 14, 2015

Reliable evidence from placebo-controlled, randomized, clinical trials for menopausal hormone therapy's influence on incidence and deaths from breast cancerR T Chlebowski, G L Anderson, R L Prentice, et al.

Pageof 8